Difficulty: Medium
Average Score: 76%
Practice
A 30-year-old woman suffering from endogenous depression improved after one month of treatment with amitriptyline. How long should the drug be continued?
Correct answer
B
Rationale
The correct answer is B) Chlorgiline. Chlorgiline is a type of irreversible monoamine oxidase inhibitor (MAOI) used in the treatment of depression. In the scenario provided, the patient improved after one month of treatment with amitriptyline, indicating a positive response to antidepressant therapy. Since endogenous depression often requires long-term treatment to prevent relapse, switching to an MAOI like chlorgiline would be appropriate for maintenance therapy.
Option A) Selegiline is a selective MAO-B inhibitor primarily used in the treatment of Parkinson's disease and not typically indicated for depression.
Option C) Moclobemide is a reversible MAOI that may be used in the treatment of depression, but chlorgiline is a more suitable option for long-term maintenance therapy.
Option D) Tranylcypromine is another type of MAOI, but chlorgiline is a better choice for maintenance therapy due to its irreversible nature.
In an educational context, understanding the mechanisms of action and appropriate use of different classes of antidepressants is crucial for effective pharmacological treatment of depression. It is important for healthcare professionals to be able to differentiate between various antidepressants to tailor treatment plans to individual patient needs and optimize outcomes.
Option A) Selegiline is a selective MAO-B inhibitor primarily used in the treatment of Parkinson's disease and not typically indicated for depression.
Option C) Moclobemide is a reversible MAOI that may be used in the treatment of depression, but chlorgiline is a more suitable option for long-term maintenance therapy.
Option D) Tranylcypromine is another type of MAOI, but chlorgiline is a better choice for maintenance therapy due to its irreversible nature.
In an educational context, understanding the mechanisms of action and appropriate use of different classes of antidepressants is crucial for effective pharmacological treatment of depression. It is important for healthcare professionals to be able to differentiate between various antidepressants to tailor treatment plans to individual patient needs and optimize outcomes.